These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
23. The impact of pharmacogenetics on the development and use of antipsychotic drugs. Reynolds GP Drug Discov Today; 2007 Nov; 12(21-22):953-9. PubMed ID: 17993414 [TBL] [Abstract][Full Text] [Related]
24. Current applications of clinical genetic testing for psychiatric practice. Mrazek DA Minn Med; 2007 Jan; 90(1):42-3. PubMed ID: 17305105 [TBL] [Abstract][Full Text] [Related]
25. Treating tobacco dependence: state of the science and new directions. Lerman C; Patterson F; Berrettini W J Clin Oncol; 2005 Jan; 23(2):311-23. PubMed ID: 15637394 [TBL] [Abstract][Full Text] [Related]
26. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials. EFSA GMO Panel Working Group on Animal Feeding Trials Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408 [TBL] [Abstract][Full Text] [Related]
28. [Pharmacogenetics of anticancer drugs]. de Chaisemartin L; Loriot MA Pathol Biol (Paris); 2005 Mar; 53(2):116-24. PubMed ID: 15708657 [TBL] [Abstract][Full Text] [Related]
29. The role of pharmacogenetics in treating central nervous system disorders. Patnaik M; Renda MJ; Athanasiou MC; Reed CR Exp Biol Med (Maywood); 2008 Dec; 233(12):1504-9. PubMed ID: 18849543 [TBL] [Abstract][Full Text] [Related]
30. The promise of pharmacogenetics: assessing the prospects for disease and patient stratification. Smart A; Martin P Stud Hist Philos Biol Biomed Sci; 2006 Sep; 37(3):583-601. PubMed ID: 16980196 [TBL] [Abstract][Full Text] [Related]
31. Translation of pharmacogenomics and pharmacogenetics: a regulatory perspective. Lesko LJ; Woodcock J Nat Rev Drug Discov; 2004 Sep; 3(9):763-9. PubMed ID: 15340386 [TBL] [Abstract][Full Text] [Related]
32. Role of CYP pharmacogenetics and drug-drug interactions in the efficacy and safety of atypical and other antipsychotic agents. Murray M J Pharm Pharmacol; 2006 Jul; 58(7):871-85. PubMed ID: 16805946 [TBL] [Abstract][Full Text] [Related]
33. Discordance between availability of pharmacogenetics studies and pharmacogenetics-based prescribing information for the top 200 drugs. Zineh I; Pebanco GD; Aquilante CL; Gerhard T; Beitelshees AL; Beasley BN; Hartzema AG Ann Pharmacother; 2006 Apr; 40(4):639-44. PubMed ID: 16595569 [TBL] [Abstract][Full Text] [Related]
34. Pharmacogenomics: historical perspective and current status. Kalow W Methods Mol Biol; 2005; 311():3-15. PubMed ID: 16100395 [TBL] [Abstract][Full Text] [Related]
35. Pharmacogenetics for individualized cancer chemotherapy. Efferth T; Volm M Pharmacol Ther; 2005 Aug; 107(2):155-76. PubMed ID: 15890408 [TBL] [Abstract][Full Text] [Related]
36. Pathways to the best fit of triptans for migraine patients. Buzzi MG Cephalalgia; 2008 Sep; 28 Suppl 2():21-7. PubMed ID: 18715329 [TBL] [Abstract][Full Text] [Related]
38. [From ready-made to tailor-made--future possibilities for individualized drug therapy]. Spigset O Tidsskr Nor Laegeforen; 2000 Jan; 120(1):73-6. PubMed ID: 10815489 [TBL] [Abstract][Full Text] [Related]
39. The interface between pharmacoepidemiology and pharmacogenetics. Maitland-van der Zee AH ; de Boer A ; Leufkens HG Eur J Pharmacol; 2000 Dec; 410(2-3):121-130. PubMed ID: 11134664 [TBL] [Abstract][Full Text] [Related]